×
About 8,863 results

ALLMedicine™ Stroke Prevention Center

Research & Reviews  2,545 results

Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
https://doi.org/10.1161/CIRCULATIONAHA.122.060274
Circulation Rillig A, Borof K et. al.

Aug 16th, 2022 - The randomized EAST-AFNET4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial-Atrial Fibrillation Network) demonstrated that early rhythm control (ERC) reduces adverse cardiovascular outcomes in patients with recently diagnosed at...

Heritability of R2* iron in the basal ganglia and cortex.
https://doi.org/10.18632/aging.204212
Aging Hofer E, Pirpamer L et. al.

Aug 12th, 2022 - While iron is essential for normal brain functioning, elevated concentrations are commonly found in neurodegenerative diseases and are associated with impaired cognition and neurological deficits. Currently, only little is known about genetic and ...

Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
https://clinicaltrials.gov/ct2/show/NCT03892824

Aug 10th, 2022 - The Vine™ filter (Vine™ or implant) is a permanent carotid filter designed for stroke prevention in AF patients taking OAC at high stroke risk (CHA2DS2-VASc ≤ 4 and stroke history). This patient population accounts for ~20% of the entire AF popula...

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing
https://clinicaltrials.gov/ct2/show/NCT03126214

Aug 10th, 2022 - Background: AF is the most common arrhythmia and the leading cause of stroke. Despite robust evidence oral anticoagulation (OAC) therapy is effective and safe for stroke prevention in patients with AF; there is a lack of real-world application. Al...

Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
https://clinicaltrials.gov/ct2/show/NCT05130268

Aug 9th, 2022 - Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, accounting for one-third of arrhythmia-related hospitalizations.1 As many as 1 in 4 people develop AF over their lifetime after the age of 40 years....

see more →

Guidelines  11 results

Heart Rhythm Society Atrial Fibrillation Centers of Excellence Study: A survey analysis...
https://doi.org/10.1016/j.hrthm.2022.02.022
Heart Rhythm; Sandhu RK, Seiler A et. al.

Apr 17th, 2022 - An integrated, coordinated, and patient-centered approach to atrial fibrillation (AF) care delivery may improve outcomes and reduce cost. The purpose of this study was to gain a better understanding from key stakeholder groups on current practices...

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Adv...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967328
Neurology Turan TN, Zaidat OO et. al.

Mar 23rd, 2022 - To review treatments for reducing the risk of recurrent stroke or death in patients with symptomatic intracranial atherosclerotic arterial stenosis (sICAS). The development of this practice advisory followed the process outlined in the American Ac...

2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on St...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763451
Thrombosis and Haemostasis; Chao TF, Joung B et. al.

Nov 14th, 2021 - The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practiti...

Society for Vascular Surgery clinical practice guidelines for management of extracrania...
https://doi.org/10.1016/j.jvs.2021.04.073
Journal of Vascular Surgery; AbuRahma AF, Avgerinos ED et. al.

Jun 22nd, 2021 - Management of carotid bifurcation stenosis in stroke prevention has been the subject of extensive investigations, including multiple randomized controlled trials. The proper treatment of patients with carotid bifurcation disease is of major intere...

Medical Care of Adults With Down Syndrome: A Clinical Guideline.
https://doi.org/10.1001/jama.2020.17024
JAMA Tsou AY, Bulova P et. al.

Oct 21st, 2020 - Down syndrome is the most common chromosomal condition, and average life expectancy has increased substantially, from 25 years in 1983 to 60 years in 2020. Despite the unique clinical comorbidities among adults with Down syndrome, there are no cli...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  269 results

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing
https://clinicaltrials.gov/ct2/show/NCT03126214

Aug 10th, 2022 - Background: AF is the most common arrhythmia and the leading cause of stroke. Despite robust evidence oral anticoagulation (OAC) therapy is effective and safe for stroke prevention in patients with AF; there is a lack of real-world application. Al...

Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants
https://clinicaltrials.gov/ct2/show/NCT03892824

Aug 10th, 2022 - The Vine™ filter (Vine™ or implant) is a permanent carotid filter designed for stroke prevention in AF patients taking OAC at high stroke risk (CHA2DS2-VASc ≤ 4 and stroke history). This patient population accounts for ~20% of the entire AF popula...

Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
https://clinicaltrials.gov/ct2/show/NCT05130268

Aug 9th, 2022 - Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, accounting for one-third of arrhythmia-related hospitalizations.1 As many as 1 in 4 people develop AF over their lifetime after the age of 40 years....

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
https://clinicaltrials.gov/ct2/show/NCT03907046

Jul 29th, 2022 - ASPIRE is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent ICH and high-risk non-valvular AF (CHA2DS2-VASc score ≥ 2). Seven hundre...

Therapy Strategies After LAA Occluder Device Embolization
https://clinicaltrials.gov/ct2/show/NCT05014477

Jul 26th, 2022 - The global burden of atrial fibrillation (AF) is high, and AF represents a major cause of morbidity, mortality and health-care expenditure. Thromboembolic stroke may be one of the fatal complications and oral anticoagulation has been the mainstay ...

see more →

News  715 results

US Supreme Court Rejects Bayer Bid to Nix Roundup Weedkiller Suits
https://www.medscape.com/viewarticle/976008

Jun 22nd, 2022 - WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Tuesday rejected Bayer AG's bid to dismiss legal claims by customers who contend its Roundup weedkiller causes cancer as the German company seeks to avoid potentially billions of dollars in...

Recurrent Stroke Risk High in AF, Even With Anticoagulants
https://www.medscape.com/viewarticle/973963

May 13th, 2022 - Patients with atrial fibrillation (AF) who suffer an ischemic stroke while taking direct oral anticoagulants (DOACs) or vitamin K antagonists (VKA) have a dangerously high risk of recurrent stroke and death, a new study shows. Researchers found a ...

Lupus may lead to worse stroke outcomes for women, but not men
https://www.mdedge.com/rheumatology/article/254233/lupus-connective-tissue-diseases/lupus-may-lead-worse-stroke-outcomes
Sara Freeman

Apr 29th, 2022 - Women with systemic lupus erythematosus (SLE) experience worse outcomes after an acute stroke than does the general population, but men with SLE do not, according to an analysis of the U. S.

Does Cilostazol Prevent Recurrent Stroke in Women?
https://www.medscape.com/viewarticle/970725

Mar 22nd, 2022 - Long-term dual antiplatelet therapy (DAPT) using cilostazol significantly reduces recurrent ischemic stroke in men, but not in women, new data suggest. In a subanalysis of results on about 2000 patients in the Cilostazol Stroke Prevention Study Co...

USPSTF releases updated guidance on asymptomatic A-fib
https://www.mdedge.com/familymedicine/article/251911/cardiology/uspstf-releases-updated-guidance-asymptomatic-fib
MDedge Family Medicine; Doug Campos-Outcalt, MD, MPA

Mar 1st, 2022 - In January 2022, the US Preventive Services Task Force updated its 2018 statement on screening for atrial fibrillation (AF) in older adults (≥ 50 years). 1,2 The supporting evidence review sought to include data on newer screening methods, such as.

see more →

Patient Education  1 results see all →